{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T08:47:03Z","timestamp":1790930823373,"version":"4.1.0"},"reference-count":308,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1053\/j.gastro.2010.04.053","type":"journal-article","created":{"date-parts":[[2010,5,6]],"date-time":"2010-05-06T04:31:28Z","timestamp":1273120288000},"page":"58-72.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":219,"title":["Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis"],"prefix":"10.1053","volume":"139","author":[{"given":"Albert J.","family":"Czaja","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2010.04.053_bib1","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib2","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1002\/hep.23584","article-title":"Practice Guidelines of the American Association for the Study of Liver Diseases. Diagnosis and management of autoimmune hepatitis","volume":"51","author":"Manns","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1586\/17474124.1.1.113","article-title":"Autoimmune hepatitis","volume":"1","author":"Czaja","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib4","first-page":"313","article-title":"Diverse manifestations and evolving treatments of autoimmune hepatitis","volume":"51","author":"Czaja","year":"2005","journal-title":"Minerva Gastroenterol Dietol"},{"key":"10.1053\/j.gastro.2010.04.053_bib5","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.3748\/wjg.15.2314","article-title":"Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment","volume":"15","author":"Czaja","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1055\/s-0029-1233530","article-title":"Special clinical challenges in autoimmune hepatitis: the elderly, males, pregnancy, mild disease, fulminant onset, and nonwhite patients","volume":"29","author":"Czaja","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-009-1122-8","article-title":"Emerging opportunities for site-specific molecular and cellular interventions in autoimmune hepatitis","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/00004836-200207000-00016","article-title":"Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients","volume":"35","author":"Kogan","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib9","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.20732","article-title":"Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome","volume":"42","author":"Feld","year":"2005","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib10","first-page":"138","article-title":"Anti-liver-kidney microsome antibody-positive autoimmune hepatitis presenting as fulminant liver failure","volume":"11","author":"Porta","year":"1990","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2010.04.053_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1542-3565(04)00246-0","article-title":"Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis","volume":"2","author":"Kessler","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S0022-3476(05)82892-6","article-title":"Autoimmune hepatitis with initial presentation as acute hepatic failure in young children","volume":"116","author":"Maggiore","year":"1990","journal-title":"J Pediatr"},{"key":"10.1053\/j.gastro.2010.04.053_bib13","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1111\/j.1365-2036.2006.02894.x","article-title":"Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases","volume":"23","author":"Miyake","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2010.04.053_bib14","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/00000478-199506000-00010","article-title":"Recent-onset autoimmune hepatitis","volume":"19","author":"Burgart","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib15","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1111\/j.1572-0241.2002.06052.x","article-title":"Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature","volume":"97","author":"Singh","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S1386-6346(02)00274-7","article-title":"Clinicopathological features of acute-onset autoimmune hepatitis","volume":"25","author":"Okano","year":"2003","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2010.04.053_bib17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","article-title":"Autoimmune hepatitis with centrilobular necrosis","volume":"28","author":"Misdraji","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib18","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/jcp.2005.029348","article-title":"Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation","volume":"59","author":"Hofer","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1111\/j.1872-034X.2007.00125.x","article-title":"Clinical features of Japanese type 1 autoimmune hepatitis patients with zone III necrosis","volume":"37","author":"Miyake","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2010.04.053_bib20","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1016\/j.humpath.2007.03.019","article-title":"Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis?","volume":"38","author":"Zen","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib21","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1002\/lt.21036","article-title":"Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis","volume":"13","author":"Ichai","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2010.04.053_bib22","first-page":"297","article-title":"Steroid therapy in fulminant hepatic failure secondary to autoimmune hepatitis","volume":"17","author":"Viruet","year":"1998","journal-title":"P R Health Sci J"},{"key":"10.1053\/j.gastro.2010.04.053_bib23","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/0016-5085(88)90503-3","article-title":"Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis","volume":"95","author":"Czaja","year":"1988","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib24","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/imj.1968.17.3.214","article-title":"Natural history of active chronic hepatitis","volume":"17","author":"Mistilis","year":"1968","journal-title":"Australas Ann Med"},{"key":"10.1053\/j.gastro.2010.04.053_bib25","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/gut.19.6.510","article-title":"Long-term follow-up of chronic active hepatitis of moderate severity","volume":"19","author":"De Groote","year":"1978","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_bib26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1478-3231.2008.01904.x","article-title":"Features and consequences of untreated type 1 autoimmune hepatitis","volume":"29","author":"Czaja","year":"2009","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_bib27","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1002\/hep.510250308","article-title":"Autoimmune hepatitis in childhood: a 20-year experience","volume":"25","author":"Gregorio","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib28","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/hep.21074","article-title":"Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly","volume":"43","author":"Czaja","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib29","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/0016-5085(92)91518-9","article-title":"Frequency and significance of antibodies to liver\/kidney microsome type 1 in adults with chronic active hepatitis","volume":"103","author":"Czaja","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib30","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.1840070626","article-title":"Chronic active hepatitis associated with antiliver\/kidney microsome antibody type 1: a second type of \u201cautoimmune\u201d hepatitis","volume":"7","author":"Homberg","year":"1987","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib31","first-page":"1206","article-title":"The validity and importance of subtypes in autoimmune hepatitis: a point of view","volume":"90","author":"Czaja","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib32","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/0016-5085(93)90656-W","article-title":"The nature and prognosis of severe cryptogenic chronic active hepatitis","volume":"104","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0025-6196(12)62106-5","article-title":"Clinical features and prognostic implications of severe corticosteroid-treated cryptogenic chronic active hepatitis","volume":"65","author":"Czaja","year":"1990","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.gastro.2010.04.053_bib34","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1055\/s-0028-1109146","article-title":"Presumed cryptogenic liver disease in Germany: High prevalence of autoantibody-negative autoimmune hepatitis, low prevalence of NASH, no evidence for occult viral etiology","volume":"47","author":"Heringlake","year":"2009","journal-title":"Z Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib35","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-006-9665-4","article-title":"Corticosteroid-responsive cryptogenic chronic hepatitis: evidence for seronegative autoimmune hepatitis","volume":"52","author":"Gassert","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_bib36","first-page":"439","article-title":"Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis","volume":"9","author":"Terjung","year":"2004","journal-title":"Eur J Med Res"},{"key":"10.1053\/j.gastro.2010.04.053_bib37","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1136\/gut.51.2.259","article-title":"Establishment of standardised SLA\/LP immunoassays: specificity for autoimmune hepatitis, worldwide occurrence, and clinical characteristics","volume":"51","author":"Baeres","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(00)80361-X","article-title":"Antibodies to soluble liver antigen: an additional marker in type 1 auto-immune hepatitis","volume":"33","author":"Ballot","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib39","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S1542-3565(04)00354-4","article-title":"Features and outcome of autoimmune hepatitis type 2 presenting with isolated positivity for anti-liver cytosol antibody","volume":"2","author":"Bridoux-Henno","year":"2004","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1053\/jhep.2001.27562","article-title":"Autoimmune hepatitis with incidental histologic features of bile duct injury","volume":"34","author":"Czaja","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib41","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1111\/j.1478-3231.2004.0924.x","article-title":"Diagnostic and therapeutic implications of bile duct injury in autoimmune hepatitis","volume":"24","author":"Czaja","year":"2004","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_bib42","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1600-0676.1984.tb00914.x","article-title":"Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology","volume":"4","author":"Ludwig","year":"1984","journal-title":"Liver"},{"key":"10.1053\/j.gastro.2010.04.053_bib43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1002\/hep.22073","article-title":"Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: evaluating the role of routine magnetic resonance imaging","volume":"47","author":"Abdalian","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib44","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0168-8278(92)90178-R","article-title":"Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis","volume":"14","author":"Perdigoto","year":"1992","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib46","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/hep.510280210","article-title":"Frequency and nature of the variant syndromes of autoimmune liver disease","volume":"28","author":"Czaja","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib47","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3748\/wjg.v16.i8.934","article-title":"Difficult treatment decisions in autoimmune hepatitis","volume":"16","author":"Czaja","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0168-8278(96)80266-2","article-title":"Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis","volume":"24","author":"Gohlke","year":"1996","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib49","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1572-0241.1998.224_a.x","article-title":"Autoimmune hepatitis overlapping with primary sclerosing cholangitis in five cases","volume":"93","author":"McNair","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib50","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib51","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy","volume":"28","author":"Chazouilleres","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib52","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","article-title":"Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals","volume":"29","author":"Lohse","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib53","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1440-1746.2006.04252.x","article-title":"Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid","volume":"21","author":"Renou","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib54","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/j.1572-0241.2001.05272.x","article-title":"Autoimmune hepatitis in African Americans: presenting features and response to therapy","volume":"96","author":"Lim","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib55","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1440-1746.1998.tb00674.x","article-title":"Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis","volume":"13","author":"Nakamura","year":"1998","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib56","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/hep.510300611","article-title":"Pediatric and adult forms of type I autoimmune hepatitis in Argentina: evidence for differential genetic predisposition","volume":"30","author":"Pando","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib57","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S0168-8278(02)00182-4","article-title":"Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States","volume":"37","author":"Czaja","year":"2002","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib58","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib59","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.3748\/wjg.14.4607","article-title":"Chronic liver disease in Aboriginal North Americans","volume":"14","author":"Scott","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib60","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1155\/2008\/642432","article-title":"Autoimmune hepatitis in a North American Aboriginal\/First Nations population","volume":"22","author":"Minuk","year":"2008","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib61","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/gut.50.5.713","article-title":"Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin","volume":"50","author":"Zolfino","year":"2002","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_bib62","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1478-3231.2005.01088.x","article-title":"An unusual form of autoimmune hepatitis in young Somalian men","volume":"25","author":"D'Souza","year":"2005","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_bib63","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1034\/j.1600-0528.2002.017401.x","article-title":"Genetic susceptibilities for immune expression and liver cell injury in autoimmune hepatitis","volume":"174","author":"Czaja","year":"2000","journal-title":"Immunol Rev"},{"key":"10.1053\/j.gastro.2010.04.053_bib64","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1089-3261(02)00023-5","article-title":"Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis","volume":"6","author":"Donaldson","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib65","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cgh.2007.12.048","article-title":"Genetic factors affecting the occurrence, clinical phenotype, and outcome of autoimmune hepatitis","volume":"6","author":"Czaja","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib66","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/hep.21884","article-title":"The impact of ethnicity on the natural history of autoimmune hepatitis","volume":"46","author":"Verma","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib67","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1111\/j.1572-0241.2008.02022.x","article-title":"Risk factors for chronic liver disease in Blacks, Mexican Americans, and Whites in the United States: results from NHANES IV, 1999\u20132004","volume":"103","author":"Flores","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib68","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1002\/hep.22223","article-title":"Racial disparity in liver disease: biological, cultural, or socioeconomic factors","volume":"47","author":"Nguyen","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib69","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF02093820","article-title":"Validation of scoring system for diagnosis of autoimmune hepatitis","volume":"41","author":"Czaja","year":"1996","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_bib70","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/hep.22322","article-title":"Simplified criteria for the diagnosis of autoimmune hepatitis","volume":"48","author":"Hennes","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib71","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1002\/hep.22513","article-title":"Performance parameters of the diagnostic scoring systems for autoimmune hepatitis","volume":"48","author":"Czaja","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib72","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1002\/hep.23042","article-title":"Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group (IAIHG) criteria in acute and chronic liver disease","volume":"50","author":"Yeoman","year":"2009","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib73","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ajg.2009.616","article-title":"Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis","volume":"105","author":"Neuhauser","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib74","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-0029-1233532","article-title":"Scoring systems for the diagnosis of autoimmune hepatitis: past, present, and future","volume":"29","author":"Wiegard","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0065-2423(05)40004-9","article-title":"Autoantibodies in autoimmune liver disease","volume":"40","author":"Czaja","year":"2005","journal-title":"Adv Clin Chem"},{"key":"10.1053\/j.gastro.2010.04.053_bib76","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1055\/s-0029-1233533","article-title":"Autoantibodies and their antigens in autoimmune hepatitis","volume":"29","author":"Bogdanos","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib77","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-010-1268-4","article-title":"Autoantibodies as prognostic markers in autoimmune hepatitis","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_bib78","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(87)92024-1","article-title":"Characterisation of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen","volume":"1","author":"Manns","year":"1987","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840180102","article-title":"Characterization and clinical relevance of liver-pancreas antibodies in autoimmune hepatitis","volume":"18","author":"Stechemesser","year":"1993","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib80","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1046\/j.1365-2249.2000.01280.x","article-title":"Isolation and characterization of cDNA encoding the antigenic protein of the human tRNP(Ser)Sec complex recognized by autoantibodies from patients withtype-1 autoimmune hepatitis","volume":"121","author":"Costa","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib81","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1073\/pnas.89.20.9739","article-title":"Autoantibodies against a serine tRNA-protein complex implicated in cotranslational selenocysteine insertion","volume":"89","author":"Gelpi","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2010.04.053_bib82","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0140-6736(00)02166-8","article-title":"Identification of target antigen for SLA\/LP autoantibodies in autoimmune hepatitis","volume":"355","author":"Wies","year":"2000","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_bib83","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1053\/jhep.2001.22218","article-title":"Soluble liver antigen: isolation of a 35-kd recombinant protein (SLA-p35) specifically recognizing sera from patients with autoimmune hepatitis","volume":"33","author":"Volkmann","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib84","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1572-0241.2002.05479.x","article-title":"Antibodies to soluble liver antigen\/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis","volume":"97","author":"Czaja","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib85","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1053\/jhep.2002.32092","article-title":"Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease","volume":"35","author":"Ma","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib86","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1080\/0891693021000054101","article-title":"Frequency and significance of antibodies to soluble liver antigen\/liver pancreas in variant autoimmune hepatitis","volume":"35","author":"Czaja","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1053\/j.gastro.2010.04.053_bib87","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0016-5085(92)90041-V","article-title":"HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients","volume":"103","author":"Seki","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib88","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jhep.2004.12.019","article-title":"Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis","volume":"42","author":"Yoshizawa","year":"2005","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_bib89","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0896-8411(03)00084-2","article-title":"Low frequency of anti-SLA\/LP autoantibody in Japanese adult patients with autoimmune liver diseases: analysis with recombinant antigen assay","volume":"21","author":"Miyakawa","year":"2003","journal-title":"J Autoimmun"},{"key":"10.1053\/j.gastro.2010.04.053_bib90","first-page":"621","article-title":"Smooth muscle autoantibodies and autoantigens","volume":"38","author":"Toh","year":"1979","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib91","first-page":"266","article-title":"Anti-actin specificity of human smooth muscle antibodies in chronic active hepatitis","volume":"24","author":"Lidman","year":"1976","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/jcp.29.5.403","article-title":"Classification of smooth muscle autoantibodies detected by immunofluorescence","volume":"29","author":"Bottazzo","year":"1976","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0022-1759(90)90291-3","article-title":"Anti-actin antibodies: a new test for an old problem","volume":"130","author":"Fusconi","year":"1990","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.gastro.2010.04.053_bib94","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/hep.510240515","article-title":"Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis","volume":"24","author":"Czaja","year":"1996","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib95","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1111\/j.1572-0241.2006.00830.x","article-title":"Evaluation of F-actin ELISA for the diagnosis of autoimmune hepatitis","volume":"101","author":"Frenzel","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib96","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1196\/annals.1313.028","article-title":"Diagnostic value of anti-F-actin antibodies in a French multicenter study","volume":"1050","author":"Chretien-Leprince","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1053\/j.gastro.2010.04.053_bib97","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jcp.2005.027367","article-title":"Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis","volume":"59","author":"Granito","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.gastro.2010.04.053_bib98","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s10875-006-9045-z","article-title":"Double reactivity against actin and alpha-actinin defines a severe form of autoimmune hepatitis type 1","volume":"26","author":"Gueguen","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib99","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s12016-007-8050-1","article-title":"Anti-alpha-actinin antibodies cross-react with anti-ssDNA antibodies in active autoimmune hepatitis","volume":"34","author":"Renaudineau","year":"2008","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jim.2008.07.011","article-title":"An actin-myosin functional assay for analysis of smooth muscle (anti-microfilament) autoantibodies in human plasma","volume":"338","author":"Martinez-Neira","year":"2008","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.gastro.2010.04.053_bib101","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0016-5085(99)70186-1","article-title":"Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis","volume":"116","author":"Lapierre","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib102","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1053\/jhep.2001.27179","article-title":"Distinct epitopes on formiminotransferase cyclodeaminase induce autoimmune liver cytosol antibody type 1","volume":"34","author":"Muratori","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib103","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.yexcr.2003.09.009","article-title":"Characterization of the antigenicity of the formiminotransferase-cyclodeaminase in type 2 autoimmune hepatitis","volume":"292","author":"Renous","year":"2004","journal-title":"Exp Cell Res"},{"key":"10.1053\/j.gastro.2010.04.053_bib104","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1002\/hep.1840080632","article-title":"Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2","volume":"8","author":"Martini","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib105","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/hep.1840160407","article-title":"Characterization of the liver cytosol antigen type 1 reacting with autoantibodies in chronic active hepatitis","volume":"16","author":"Abuaf","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib106","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1136\/gut.42.5.721","article-title":"Liver\/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis","volume":"42","author":"Muratori","year":"1998","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_bib107","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0022-1759(95)00192-X","article-title":"Detection of anti-liver cytosol antibody type 1 (anti-LC1) by immunodiffusion, counterimmunoelectrophoresis and immunoblotting: comparison of different techniques","volume":"187","author":"Muratori","year":"1995","journal-title":"J Immunol Methods"},{"key":"10.1053\/j.gastro.2010.04.053_bib108","first-page":"58","article-title":"Anti-liver cytosolic antigen type 1 (LC1) antibodies in childhood autoimmune liver disease","volume":"21","author":"Han","year":"1995","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib109","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.36.5.749","article-title":"Liver cytosolic 1 antigen-antibody system in type 2 autoimmune hepatitis and hepatitis C virus infection","volume":"36","author":"Lenzi","year":"1995","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_bib110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jaut.2003.11.001","article-title":"Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection","volume":"22","author":"Beland","year":"2004","journal-title":"J Autoimmun"},{"key":"10.1053\/j.gastro.2010.04.053_bib111","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/08916930410001702469","article-title":"Nonstandard antibodies as prognostic markers in autoimmune hepatitis","volume":"37","author":"Czaja","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1053\/j.gastro.2010.04.053_bib112","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(94)91966-6","article-title":"Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D","volume":"344","author":"Philipp","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_bib113","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0016-5085(95)90074-8","article-title":"Heterogeneity of liver-kidney microsomal autoantibodies in chronic hepatitis C and D virus infection","volume":"108","author":"Durazzo","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib114","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0016-5085(96)70020-3","article-title":"Autoantibodies against glucuronosyltransferases differ between viral hepatitis and autoimmune hepatitis","volume":"111","author":"Strassburg","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib115","first-page":"232","article-title":"Microsomal autoantibodies in chronic infection with the HBsAg associated delta (delta) agent","volume":"54","author":"Crivelli","year":"1983","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib116","doi-asserted-by":"crossref","first-page":"36164","DOI":"10.1074\/jbc.M002180200","article-title":"Polymorphic gene regulation and interindividual variation of UDP-glucuronosyltransferase activity in human small intestine","volume":"275","author":"Strassburg","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1053\/j.gastro.2010.04.053_bib117","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00351174","article-title":"Cytochrome P450 enzymes and UDP-glucuronosyltransferases as hepatocellular autoantigens","volume":"23","author":"Obermayer-Straub","year":"1996","journal-title":"Mol Biol Rep"},{"key":"10.1053\/j.gastro.2010.04.053_bib118","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/hep.510260438","article-title":"Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease","volume":"26","author":"Manns","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib119","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/hep.1840130415","article-title":"Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors","volume":"13","author":"Donaldson","year":"1991","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib120","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1053\/gast.1997.v112.pm9178696","article-title":"Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis","volume":"112","author":"Strettell","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib121","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.1840190311","article-title":"Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis","volume":"19","author":"Doherty","year":"1994","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib122","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/j.1478-3231.2006.01387.x","article-title":"Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis","volume":"26","author":"Montano-Loza","year":"2006","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_bib123","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/hep.510250211","article-title":"Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis","volume":"25","author":"Czaja","year":"1997","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib124","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/0016-5085(93)90157-8","article-title":"Significance of HLA DR4 in type 1 autoimmune hepatitis","volume":"105","author":"Czaja","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib125","first-page":"2197","article-title":"Genetic distinctions between types 1 and 2 autoimmune hepatitis","volume":"92","author":"Czaja","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib126","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1572-0241.1999.01229.x","article-title":"Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2","volume":"94","author":"Bittencourt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_bib127","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0198-8859(94)90008-6","article-title":"Chronic active autoimmune hepatitis in children","volume":"41","author":"Fainboim","year":"1994","journal-title":"Hum Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib128","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0198-8859(00)00234-2","article-title":"Analysis of HLA haplotypes in autoimmune hepatitis type 1: identifying the major susceptibility locus","volume":"62","author":"Goldberg","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib129","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1055\/s-2002-35703","article-title":"Animal models of autoimmune hepatitis","volume":"22","author":"Jaeckel","year":"2002","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.autrev.2006.04.001","article-title":"Animal models for autoimmune hepatitis","volume":"6","author":"Christen","year":"2007","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2010.04.053_bib131","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1055\/s-0029-1233536","article-title":"New animal models for autoimmune hepatitis","volume":"29","author":"Christen","year":"2009","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib132","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/hep.20109","article-title":"A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens","volume":"39","author":"Lapierre","year":"2004","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_bib133","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2005.11.001","article-title":"Type 2 autoimmune hepatitis murine model: the influence of genetic background in disease development","volume":"26","author":"Lapierre","year":"2006","journal-title":"J Autoimmun"},{"key":"10.1053\/j.gastro.2010.04.053_bib134","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1084\/jem.20071859","article-title":"Breaking tolerance to the natural human liver autoantigen cytochrome P450 2D6 by virus infection","volume":"205","author":"Holdener","year":"2008","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2010.04.053_bib135","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1172\/JCI115443","article-title":"LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase","volume":"88","author":"Manns","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2010.04.053_bib136","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","article-title":"Cytochrome P4502D6(193-212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease","volume":"170","author":"Kerkar","year":"2003","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib137","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1096\/fasebj.12.13.1255","article-title":"Molecular mimicry and immune-mediated diseases","volume":"12","author":"Oldstone","year":"1998","journal-title":"FASEB J"},{"key":"10.1053\/j.gastro.2010.04.053_bib138","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1034\/j.1600-0676.2001.021004225.x","article-title":"Molecular mimicry and autoimmune liver disease: virtuous intentions, malign consequences","volume":"21","author":"Bogdanos","year":"2001","journal-title":"Liver"},{"key":"10.1053\/j.gastro.2010.04.053_bib139","first-page":"1353","article-title":"Cytochrome P450 1A2 is a hepatic autoantigen in autoimmune polyglandular syndrome type 1","volume":"82","author":"Clemente","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.gastro.2010.04.053_bib140","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0016-5085(98)70484-6","article-title":"Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1","volume":"114","author":"Clemente","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib141","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1053\/gast.2001.27103","article-title":"Hepatic autoantigens in patients with autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"121","author":"Obermayer-Straub","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_bib142","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1172\/JCI114660","article-title":"Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2","volume":"85","author":"Bourdi","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2010.04.053_bib143","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0003-9861(90)90541-6","article-title":"Identification of cytochrome P450IA2 as a human autoantigen","volume":"280","author":"Manns","year":"1990","journal-title":"Arch Biochem Biophys"},{"key":"10.1053\/j.gastro.2010.04.053_bib144","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.4049\/jimmunol.161.7.3527","article-title":"Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR","volume":"161","author":"Doherty","year":"1998","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib145","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1046\/j.1365-2249.2003.02229.x","article-title":"Mimicry between the hepatitis C virus polyprotein and antigenic targets of nuclear and smooth muscle antibodies in chronic hepatitis C virus infection","volume":"133","author":"Gregorio","year":"2003","journal-title":"Clin Exp Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_bib146","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/039463200401700112","article-title":"Multiple viral\/self immunological cross-reactivity in liver kidney microsomal antibody positive hepatitis C virus infected patients is associated with the possession of HLA B51","volume":"17","author":"Bogdanos","year":"2004","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1053\/j.gastro.2010.04.053_bib147","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1084\/jem.190.2.169","article-title":"Molecular mimicry of human cytochrome P450 by hepatitis C virus at the level of cytotoxic T cell recognition","volume":"190","author":"Kammer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1053\/j.gastro.2010.04.053_bib148","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1056\/NEJM199912303412707","article-title":"Molecular mimicry and autoimmunity","volume":"341","author":"Albert","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_bib149","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1089-3261(02)00018-1","article-title":"Pathogenesis of autoimmune hepatitis","volume":"6","author":"Vergani","year":"2002","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2010.04.053_bib150","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jhep.2006.07.034","article-title":"HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis","volume":"45","author":"Djilali-Saiah","year":"2006","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr151","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10620-006-9495-4","article-title":"Evidence of a genetic basis for the different geographic occurrences of liver\/kidney microsomal antibody type 1 in hepatitis C","volume":"52","author":"Muratori","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_fr152","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1053\/jhep.2001.24562","article-title":"Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis","volume":"33","author":"Fainboim","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr153","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/hep.510310110","article-title":"Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis","volume":"31","author":"Agarwal","year":"2000","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr154","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/S0198-8859(01)00344-5","article-title":"CTLA-4\/CD 28 region polymorphisms in children from families with autoimmune hepatitis","volume":"62","author":"Djilali-Saiah","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr155","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S0168-8278(00)80213-5","article-title":"CTLA-4 gene polymorphism confers susceptibility to primary biliary cirrhosis","volume":"32","author":"Agarwal","year":"2000","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr156","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1053\/j.gastro.2008.06.077","article-title":"Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene","volume":"135","author":"Juran","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr157","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1572-0241.2003.07525.x","article-title":"Cytotoxic T lymphocyte antigen-4 gene polymorphisms do not confer susceptibility to autoimmune hepatitis types 1 and 2 in Brazil","volume":"98","author":"Bittencourt","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr158","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1111\/j.1872-034X.2008.00337.x","article-title":"Association of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with type 1 autoimmune hepatitis in Japanese","volume":"38","author":"Umemura","year":"2008","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2010.04.053_fr159","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/eji.1830230135","article-title":"Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-alpha and TNF-beta by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus","volume":"23","author":"Pociot","year":"1993","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr160","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0016-5085(99)70458-0","article-title":"Cytokine polymorphisms associated with clinical features and treatment outcome in type 1 autoimmune hepatitis","volume":"117","author":"Czaja","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr161","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510300412","article-title":"Frequency and nature of cytokine gene polymorphisms in type 1 autoimmune hepatitis","volume":"30","author":"Cookson","year":"1999","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr162","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/j.1572-0241.2005.41053.x","article-title":"Fas polymorphisms influence susceptibility to autoimmune hepatitis","volume":"100","author":"Hiraide","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr163","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1399-0039.2006.00794.x","article-title":"A functional Fas promoter polymorphism is associated with a severe phenotype in type 1 autoimmune hepatitis characterized by early development of cirrhosis","volume":"69","author":"Agarwal","year":"2007","journal-title":"Tissue Antigens"},{"key":"10.1053\/j.gastro.2010.04.053_fr164","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.3748\/wjg.v11.i18.2768","article-title":"Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"11","author":"Fan","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr165","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1053\/jhep.2002.30084","article-title":"Genetic association of vitamin D receptor polymorphisms with primary biliary cirrhosis and autoimmune hepatitis","volume":"35","author":"Vogel","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr166","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1440-1746.2005.03532.x","article-title":"Genetic association of vitamin D receptor polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese","volume":"20","author":"Fan","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr167","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.gene.6363918","article-title":"77 C\/G mutation in the tyrosine phosphatase CD45 gene and autoimmune hepatitis: evidence for a genetic link","volume":"4","author":"Vogel","year":"2003","journal-title":"Genes Immun"},{"key":"10.1053\/j.gastro.2010.04.053_fr168","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.hepres.2005.04.006","article-title":"C77G mutation in protein tyrosine phosphatase CD45 gene and autoimmune hepatitis","volume":"32","author":"Esteghamat","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2010.04.053_fr169","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/hep.21518","article-title":"A genomewide DNA microsatellite association study of Japanese patients with autoimmune hepatitis type 1","volume":"45","author":"Yokosawa","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr170","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2005.05.001","article-title":"Effect of CD4+ CD25+ regulatory T-cells on CD8 T-cell function in patients with autoimmune hepatitis","volume":"25","author":"Longhi","year":"2005","journal-title":"J Autoimmun"},{"key":"10.1053\/j.gastro.2010.04.053_fr171","doi-asserted-by":"crossref","first-page":"4484","DOI":"10.4049\/jimmunol.176.7.4484","article-title":"Functional study of CD4+CD25+ regulatory T cells in health and autoimmune hepatitis","volume":"176","author":"Longhi","year":"2006","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr172","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr173","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.21123","article-title":"Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis","volume":"43","author":"Lan","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr174","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.22071","article-title":"Expansion and de novo generation of potentially therapeutic regulatory T cells in patients with autoimmune hepatitis","volume":"47","author":"Longhi","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr175","first-page":"241","article-title":"The regulatory effect of natural killer cells: do \u201cNK-reg cells\u201d exist?","volume":"3","author":"Zhang","year":"2006","journal-title":"Cell Mol Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr176","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2174\/138955706778742722","article-title":"Glycolipids as immune modulatory tools","volume":"6","author":"Lalazar","year":"2006","journal-title":"Mini Rev Med Chem"},{"key":"10.1053\/j.gastro.2010.04.053_fr177","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.4049\/jimmunol.176.4.2152","article-title":"P2X7 receptors regulate NKT cells in autoimmune hepatitis","volume":"176","author":"Kawamura","year":"2006","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr178","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/08830180601070195","article-title":"Invariant NKT cells and tolerance","volume":"26","author":"Nowak","year":"2007","journal-title":"Int Rev Immunol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2010.04.053_fr179","first-page":"227A","article-title":"Intrahepatic NKT cell and soluble CD1d have a significant role in the immuno-pathogenesis of AIH but not PBC (abstr)","volume":"44","author":"Takahashi","year":"2006","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1615\/CritRevImmunol.v26.i5.50","article-title":"The role of NKT cells in animal models of autoimmune hepatitis","volume":"26","author":"Dennert","year":"2006","journal-title":"Crit Rev Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr181","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1478-3231.2009.02092.x","article-title":"Identification and characterization of IgG4-associated autoimmune hepatitis","volume":"30","author":"Chung","year":"2009","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr182","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s00535-009-0054-6","article-title":"Autoimmune pancreatitis in Japan: overview and perspective","volume":"44","author":"Shimosegawa","year":"2009","journal-title":"J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr183","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1136\/gut.2007.122283","article-title":"IgG4 associated autoimmune hepatitis: a differential diagnosis for classical autoimmune hepatitis","volume":"56","author":"Umemura","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_fr184","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1586\/egh.09.15","article-title":"Current and future treatments of autoimmune hepatitis","volume":"3","author":"Czaja","year":"2009","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/oxfordjournals.qjmed.a067264","article-title":"Controlled prospective trial of corticosteroid therapy in active chronic hepatitis","volume":"40","author":"Cook","year":"1971","journal-title":"Q J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr186","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0016-5085(19)33223-8","article-title":"Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis","volume":"63","author":"Soloway","year":"1972","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr187","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(73)92125-9","article-title":"Controlled trial of prednisone and azathioprine in active chronic hepatitis","volume":"1","author":"Murray-Lyon","year":"1973","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_fr188","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.jhep.2004.01.009","article-title":"Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis","volume":"40","author":"Czaja","year":"2004","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr189","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1053\/gast.1996.v110.pm8608895","article-title":"Prognosis of histological cirrhosis in type 1 autoimmune hepatitis","volume":"110","author":"Roberts","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr190","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1586\/17474124.1.1.129","article-title":"Autoimmune hepatitis","volume":"1","author":"Czaja","year":"2007","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr191","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1572-0241.2007.01153.x","article-title":"Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse","volume":"102","author":"Montano-Loza","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr192","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/hep.1840040409","article-title":"Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis","volume":"4","author":"Czaja","year":"1984","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr193","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jhep.2009.02.026","article-title":"Rapidity of treatment response and outcome in type 1 autoimmune hepatitis","volume":"51","author":"Czaja","year":"2009","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr194","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1055\/s-2001-13708","article-title":"Long-term management and prognosis of autoimmune hepatitis (AIH): a single center experience","volume":"39","author":"Kanzler","year":"2001","journal-title":"Z Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr195","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gut.16.11.876","article-title":"Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared","volume":"16","author":"Summerskill","year":"1975","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_fr196","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1517\/14740338.7.3.319","article-title":"Safety issues in the management of autoimmune hepatitis","volume":"7","author":"Czaja","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1053\/j.gastro.2010.04.053_fr197","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1007\/s10620-006-9336-5","article-title":"Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis","volume":"51","author":"Czaja","year":"2006","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_fr198","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(86)92291-9","article-title":"Azathioprine and severe bone marrow depression","volume":"1","author":"Maddocks","year":"1986","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_fr199","first-page":"351","article-title":"Azathioprine-induced myelosuppression due to thiopurine methyltransferase deficiency in a patient with autoimmune hepatitis","volume":"23","author":"Ben Ari","year":"1995","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr200","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0168-8278(02)00214-3","article-title":"Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis","volume":"37","author":"Langley","year":"2002","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr201","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jhep.2006.05.011","article-title":"Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis","volume":"45","author":"Heneghan","year":"2006","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/gut.48.1.97","article-title":"Management and outcome of pregnancy in autoimmune hepatitis","volume":"48","author":"Heneghan","year":"2001","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_fr203","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1111\/j.1572-0241.2002.07124.x","article-title":"Improvement of autoimmune hepatitis during pregnancy followed by flare-up after delivery","volume":"97","author":"Buchel","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.1840100110","article-title":"Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis","volume":"10","author":"Wang","year":"1989","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1572-0241.2007.01609.x","article-title":"Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases","volume":"103","author":"Worns","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr206","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/hep.21787","article-title":"Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease","volume":"46","author":"Montano-Loza","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr207","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0016-5085(80)90866-5","article-title":"Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission","volume":"78","author":"Czaja","year":"1980","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr208","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM198101013040102","article-title":"Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitis","volume":"304","author":"Czaja","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr209","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0016-5085(81)90126-8","article-title":"Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic features","volume":"80","author":"Czaja","year":"1981","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr210","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0016-5085(87)90862-6","article-title":"Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis","volume":"92","author":"Czaja","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr211","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1478-3231.2007.01444.x","article-title":"Consequences of treatment withdrawal in type 1 autoimmune hepatitis","volume":"27","author":"Montano-Loza","year":"2007","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr212","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/jhep.2002.32485","article-title":"Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis","volume":"35","author":"Czaja","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr213","doi-asserted-by":"crossref","DOI":"10.1007\/s10620-010-1243-0","article-title":"Late relapse of type 1 autoimmune hepatitis after corticosteroid withdrawal","author":"Czaja","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_fr214","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.1840080414","article-title":"Maintenance of remission in autoimmune chronic active hepatitis with azathioprine after corticosteroid withdrawal","volume":"8","author":"Stellon","year":"1988","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr215","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJM199510123331502","article-title":"Azathioprine for long-term maintenance of remission in autoimmune hepatitis","volume":"333","author":"Johnson","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr216","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/hep.1840110621","article-title":"Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis","volume":"11","author":"Czaja","year":"1990","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr217","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/j.1478-3231.2005.01141.x","article-title":"Autoimmune hepatitis type 1: safety and efficacy of prolonged medical therapy","volume":"25","author":"Seela","year":"2005","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr218","doi-asserted-by":"crossref","first-page":"463","DOI":"10.5694\/j.1326-5377.1985.tb123140.x","article-title":"Cyclosporin, a new treatment for autoimmune chronic active hepatitis","volume":"143","author":"Mistilis","year":"1985","journal-title":"Med J Aust"},{"key":"10.1053\/j.gastro.2010.04.053_fr219","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/0016-5085(87)90454-9","article-title":"Cyclosporine treatment of autoimmune chronic active hepatitis","volume":"93","author":"Hyams","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr220","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00004836-199312000-00012","article-title":"A case of cyclosporine-sensitive, steroid-resistant, autoimmune chronic active hepatitis","volume":"17","author":"Person","year":"1993","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr221","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0168-8278(05)80615-4","article-title":"Cyclosporine in the management of corticosteroid-resistant type I autoimmune chronic active hepatitis","volume":"21","author":"Sherman","year":"1994","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr222","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0022-3476(99)70339-2","article-title":"Efficacy of cyclosporin A in children with type 2 autoimmune hepatitis","volume":"135","author":"Debray","year":"1999","journal-title":"J Pediatr"},{"key":"10.1053\/j.gastro.2010.04.053_fr223","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1572-0241.1999.00807.x","article-title":"Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis","volume":"94","author":"Fernandes","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr224","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1023\/A:1010683817344","article-title":"Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis","volume":"46","author":"Malekzadeh","year":"2001","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_fr225","first-page":"771","article-title":"Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial","volume":"90","author":"Van Thiel","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr226","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1053\/jlts.2001.24638","article-title":"Successful tacrolimus therapy for a severe recurrence of type 1 autoimmune hepatitis in a liver graft recipient","volume":"7","author":"Hurtova","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2010.04.053_fr227","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1097\/01.mcg.0000139050.67178.be","article-title":"Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis","volume":"38","author":"Aqel","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr228","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1478-3231.2005.01107.x","article-title":"Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus","volume":"25","author":"Chatur","year":"2005","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr229","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.3748\/wjg.v13.i23.3232","article-title":"Low-dose tacrolimus ameliorates liver inflammation and fibrosis in steroid refractory autoimmune hepatitis","volume":"13","author":"Larsen","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr230","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1053\/j.gastro.2010.04.053_fr231","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1155\/2004\/504591","article-title":"Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy","volume":"18","author":"Devlin","year":"2004","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr232","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/01.mog.0000155360.43763.41","article-title":"Autoimmune liver disease","volume":"21","author":"Czaja","year":"2005","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr233","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.cgh.2007.02.030","article-title":"Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy","volume":"5","author":"Inductivo-Yu","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr234","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1111\/j.1572-0241.2008.02180.x","article-title":"Mycophenolate mofetil as second line therapy in autoimmune hepatitis?","volume":"103","author":"Hennes","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr235","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cgh.2008.04.006","article-title":"A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis","volume":"6","author":"Hlivko","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr236","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1007\/s10620-008-0632-0","article-title":"Mycophenolate mofetil for autoimmune hepatitis: a single practice experience","volume":"54","author":"Wolf","year":"2009","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2010.04.053_fr237","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2009.02.024","article-title":"Mycophenolate mofetil as rescue treatment for autoimmune liver disease in children: a 5-year follow-up","volume":"51","author":"Aw","year":"2009","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr238","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1034\/j.1399-3046.1999.00015.x","article-title":"Mycophenolate mofetil\u2014is it worth the cost?","volume":"3","author":"Seikaly","year":"1999","journal-title":"Pediatr Transplant"},{"key":"10.1053\/j.gastro.2010.04.053_fr239","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1517\/14656566.7.2.145","article-title":"Cost-effectiveness of pharmacotherapy for autoimmune hepatitis","volume":"7","author":"Heneghan","year":"2006","journal-title":"Expert Opin Pharmacother"},{"key":"10.1053\/j.gastro.2010.04.053_fr240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.3899\/jrheum.080517","article-title":"Cost comparison between mycophenolate mofetil and cyclophosphamide-azathioprine in the treatment of lupus nephritis","volume":"36","author":"Tse","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr241","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1365-2036.1994.tb00334.x","article-title":"Oral budesonide for treatment of autoimmune chronic active hepatitis","volume":"8","author":"Danielsson","year":"1994","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2010.04.053_fr242","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.3748\/wjg.v12.i9.1362","article-title":"Budesonide induces complete remission in autoimmune hepatitis","volume":"12","author":"Csepregi","year":"2006","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr243","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1478-3231.2005.01122.x","article-title":"Budesonide in previously untreated autoimmune hepatitis","volume":"25","author":"Wiegand","year":"2005","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr244","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1155\/2008\/509459","article-title":"The use of budesonide in the treatment of autoimmune hepatitis in Canada","volume":"22","author":"Zandieh","year":"2008","journal-title":"Can J Gastroenterol"},{"issue":"Suppl 2","key":"10.1053\/j.gastro.2010.04.053_fr245","doi-asserted-by":"crossref","first-page":"S369","DOI":"10.1016\/S0168-8278(08)60991-5","article-title":"Budesonide 3 mg TID is superior to prednisolone in combination with azathioprine in the treatment of autoimmune hepatitis (abstr)","volume":"48","author":"Manns","year":"2008","journal-title":"J Hepatol"},{"issue":"Suppl 4","key":"10.1053\/j.gastro.2010.04.053_fr246","first-page":"376A","article-title":"Budesonide 3 mg BID in combination with azathioprine as maintenance treatment of autoimmune hepatitis - final results of a large multicenter international trial (abstr)","volume":"48","author":"Manns","year":"2008","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr247","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1053\/gast.2000.0010000001","article-title":"Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis","volume":"119","author":"Czaja","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr248","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.3748\/wjg.v9.i12.2681","article-title":"Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC","volume":"9","author":"Geier","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2010.04.053_fr249","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0168-8278(99)80017-8","article-title":"Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease","volume":"30","author":"Ratziu","year":"1999","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr250","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/hep.1840150208","article-title":"Prognostic features and role of liver transplantation in severe corticosteroid-treated autoimmune chronic active hepatitis","volume":"15","author":"Sanchez-Urdazpal","year":"1992","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr251","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hep.510280306","article-title":"Acute hepatic allograft rejection: incidence, risk factors, and impact on outcome","volume":"28","author":"Wiesner","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr252","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/lt.21181","article-title":"Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival","volume":"13","author":"Cross","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2010.04.053_fr253","first-page":"20","article-title":"Recurrence of autoimmune hepatitis in children after liver transplantation","volume":"25","author":"Birnbaum","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1053\/j.gastro.2010.04.053_fr254","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1053\/jlts.2001.21449","article-title":"Recurrent autoimmune hepatitis after orthotopic liver transplantation","volume":"7","author":"Gonzalez-Koch","year":"2001","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2010.04.053_fr255","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1399-0012.2004.00117.x","article-title":"Long-term outcome of liver transplantation for autoimmune hepatitis","volume":"18","author":"Vogel","year":"2004","journal-title":"Clin Transplant"},{"key":"10.1053\/j.gastro.2010.04.053_fr256","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/lt.21525","article-title":"Liver transplantation for autoimmune hepatitis and the success of aggressive corticosteroid withdrawal","volume":"14","author":"Campsen","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1053\/j.gastro.2010.04.053_fr257","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/gut.52.6.893","article-title":"A 10 year follow up study of patients transplanted for autoimmune hepatitis: histological recurrence precedes clinical and biochemical recurrence","volume":"52","author":"Duclos-Vallee","year":"2003","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2010.04.053_fr258","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2010.04.053_fr259","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/jhep.2002.31167","article-title":"Response to steroids in de novo autoimmune hepatitis after liver transplantation","volume":"35","author":"Salcedo","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr261","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1600-6143.2005.00801.x","article-title":"Rapamycin successfully treats post-transplant autoimmune hepatitis","volume":"5","author":"Kerkar","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1053\/j.gastro.2010.04.053_fr262","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI27191","article-title":"Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs","volume":"116","author":"Bresson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2010.04.053_fr263","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/hep.510280620","article-title":"Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis","volume":"28","author":"Thompson","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr264","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-3468(96)90749-6","article-title":"Viral IL-10 gene therapy inhibits TNF-alpha and IL-1 beta, not IL-6, in the newborn endotoxemic mouse","volume":"31","author":"Drazan","year":"1996","journal-title":"J Pediatr Surg"},{"key":"10.1053\/j.gastro.2010.04.053_fr265","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.172.10.6427","article-title":"Generation and regulation of human Th1-biased immune responses in vivo: a critical role for IL-4 and IL-10","volume":"172","author":"Skapenko","year":"2004","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr266","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1089\/107999099312939","article-title":"A pilot study of daily subcutaneous interleukin-10 in patients with chronic hepatitis C infection","volume":"19","author":"McHutchison","year":"1999","journal-title":"J Interferon Cytokine Res"},{"key":"10.1053\/j.gastro.2010.04.053_fr267","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0016-5085(00)70134-X","article-title":"Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders","volume":"118","author":"Nelson","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr268","first-page":"859","article-title":"Long-term interleukin 10 therapy in chronic hepatitis C patients has a proviral and anti-inflammatory effect","volume":"38","author":"Nelson","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2010.04.053_fr269","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1053\/gast.2000.20196","article-title":"Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease","volume":"119","author":"Schreiber","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr270","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1053\/gast.2000.20229","article-title":"Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease","volume":"119","author":"Fedorak","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr271","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF01541395","article-title":"Clinical, hematologic, and immunologic effects of interleukin-10 in humans","volume":"16","author":"Fuchs","year":"1996","journal-title":"J Clin Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr272","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0009-9236(97)90065-5","article-title":"Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers","volume":"62","author":"Huhn","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1053\/j.gastro.2010.04.053_fr273","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1023\/B:PHAM.0000048199.94510.b0","article-title":"Pharmacokinetic and biodistribution profile of recombinant human interleukin-10 following intravenous administration in rats with extensive liver fibrosis","volume":"21","author":"Rachmawati","year":"2004","journal-title":"Pharm Res"},{"key":"10.1053\/j.gastro.2010.04.053_fr274","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/35069112","article-title":"Structural basis for co-stimulation by the human CTLA-4\/B7-2 complex","volume":"410","author":"Schwartz","year":"2001","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2010.04.053_fr275","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1600-065X.2008.00639.x","article-title":"CTLA-4: a key regulatory point in the control of autoimmune disease","volume":"223","author":"Scalapino","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1053\/j.gastro.2010.04.053_fr276","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1056\/NEJM199906033402202","article-title":"Transplantation of anergic histoincompatible bone marrow allografts","volume":"340","author":"Guinan","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr277","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1073\/pnas.0830997100","article-title":"Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients","volume":"100","author":"Hodi","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2010.04.053_fr278","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.autrev.2008.07.035","article-title":"Co-stimulatory modulation in rheumatoid arthritis: the role of (CTLA4-Ig) abatacept","volume":"8","author":"Fiocco","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1053\/j.gastro.2010.04.053_fr279","first-page":"865","article-title":"Abatacept in difficult-to-treat juvenile idiopathic arthritis","volume":"2","author":"Kuemmerle-Deschner","year":"2008","journal-title":"Biologics"},{"key":"10.1053\/j.gastro.2010.04.053_fr280","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1212\/01.wnl.0000325915.00112.61","article-title":"CTLA4Ig treatment in patients with multiple sclerosis: an open-label, phase 1 clinical trial","volume":"71","author":"Viglietta","year":"2008","journal-title":"Neurology"},{"key":"10.1053\/j.gastro.2010.04.053_fr281","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1742-7843.2009.00375.x","article-title":"Abatacept, a novel CD80\/86-CD28 T cell co-stimulation modulator, in the treatment of rheumatoid arthritis","volume":"104","author":"Korhonen","year":"2009","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1053\/j.gastro.2010.04.053_fr282","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007277.pub2","article-title":"Abatacept for rheumatoid arthritis","author":"Maxwell","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2010.04.053_fr283","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2174\/187221309788489760","article-title":"CTLA-4Ig: uses and future directions","volume":"3","author":"Ben-Shoshan","year":"2009","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1053\/j.gastro.2010.04.053_fr284","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1600-065X.2009.00780.x","article-title":"The clinical utility of inhibiting CD28-mediated costimulation","volume":"229","author":"Linsley","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1053\/j.gastro.2010.04.053_fr285","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2249.2003.02363.x","article-title":"Blocking B7 and CD40 co-stimulatory molecules decreases antiviral T cell activity","volume":"135","author":"Vermeiren","year":"2004","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2010.04.053_fr286","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1297-319X(09)74520-8","article-title":"Abatacept therapy and safety management","volume":"76","author":"Pham","year":"2009","journal-title":"Joint Bone Spine"},{"key":"10.1053\/j.gastro.2010.04.053_fr287","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/337181a0","article-title":"Antibodies to CD3\/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures","volume":"337","author":"Smith","year":"1989","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2010.04.053_fr288","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4049\/jimmunol.142.3.737","article-title":"Effects of in vivo administration of anti-CD3 monoclonal antibody on T cell function in mice","volume":"142","author":"Hirsch","year":"1989","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr289","doi-asserted-by":"crossref","first-page":"933","DOI":"10.4049\/jimmunol.168.2.933","article-title":"Nonmitogenic CD3 antibody reverses virally induced (rat insulin promoter-lymphocytic choriomeningitis virus) autoimmune diabetes without impeding viral clearance","volume":"168","author":"von Herrath","year":"2002","journal-title":"J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/0470871628.ch21","article-title":"CD3 antibody treatment stimulates the functional capability of regulatory T cells","volume":"252","author":"Chatenoud","year":"2003","journal-title":"Novartis Found Symp"},{"key":"10.1053\/j.gastro.2010.04.053_fr291","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/nri1000","article-title":"CD3-specific antibody-induced active tolerance: from bench to bedside","volume":"3","author":"Chatenoud","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr292","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/nri2134","article-title":"CD3-specific antibodies: a portal to the treatment of autoimmunity","volume":"7","author":"Chatenoud","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr293","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.coph.2004.03.012","article-title":"Anti-CD3 antibodies: towards clinical antigen-specific immunomodulation","volume":"4","author":"Chatenoud","year":"2004","journal-title":"Curr Opin Pharmacol"},{"key":"10.1053\/j.gastro.2010.04.053_fr294","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice","volume":"91","author":"Chatenoud","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.gastro.2010.04.053_fr295","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr296","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.gastro.2010.04.053_fr297","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2337\/diabetes.54.6.1763","article-title":"A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes","volume":"54","author":"Herold","year":"2005","journal-title":"Diabetes"},{"key":"10.1053\/j.gastro.2010.04.053_fr298","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1002\/eji.1830200308","article-title":"Cytokine-related syndrome following injection of anti-CD3 monoclonal antibody: further evidence for transient in vivo T cell activation","volume":"20","author":"Ferran","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr299","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/eji.1830200337","article-title":"Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor","volume":"20","author":"Alegre","year":"1990","journal-title":"Eur J Immunol"},{"key":"10.1053\/j.gastro.2010.04.053_fr300","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1900\/RDS.2005.2.187","article-title":"Limitations in immunotherapy with CD3 antibodies: comment on the article by Drs. Chatenoud and Bach","volume":"2","author":"Bresson","year":"2005","journal-title":"Rev Diabet Stud"},{"key":"10.1053\/j.gastro.2010.04.053_fr301","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/0016-5085(94)90078-7","article-title":"Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis","volume":"107","author":"Czaja","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr302","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/0006-291X(89)90027-2","article-title":"Anti-liver-kidney microsome antibody type 1 recognizes human cytochrome P450 db1","volume":"159","author":"Gueguen","year":"1989","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1053\/j.gastro.2010.04.053_fr303","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1053\/j.gastro.2005.12.020","article-title":"Polyclonal T-cell responses to cytochrome P450IID6 are associated with disease activity in autoimmune hepatitis type 2","volume":"130","author":"Ma","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2010.04.053_fr304","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1172\/JCI113949","article-title":"Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1","volume":"83","author":"Manns","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1053\/j.gastro.2010.04.053_fr305","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0168-8278(98)80347-4","article-title":"MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis","volume":"28","author":"Vazquez-Garcia","year":"1998","journal-title":"J Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr306","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1440-1746.2003.02918.x","article-title":"Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients","volume":"18","author":"Qiu","year":"2003","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2010.04.053_fr307","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/j.1478-3231.2007.01581.x","article-title":"Genetic contribution of major histocompatibility complex class II region to type 1 autoimmune hepatitis susceptibility in Venezuela","volume":"27","author":"Fortes Mdel","year":"2007","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2010.04.053_fr308","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.3748\/wjg.v11.i12.1862","article-title":"Genetic distinctions between autoimmune hepatitis in Italy and North America","volume":"11","author":"Muratori","year":"2005","journal-title":"World J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650851000661X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001650851000661X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T14:55:06Z","timestamp":1758034506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001650851000661X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":308,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S001650851000661X"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2010.04.053","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the Diagnosis, Pathogenesis, and Management of Autoimmune Hepatitis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2010.04.053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 AGA Institute. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}